Full Text View
Tabular View
No Study Results Posted
Related Studies
A Pilot Study of Functional Optical Coherence Tomography (OCT) for Ocular Imaging
This study is enrolling participants by invitation only.
First Received: November 7, 2007   Last Updated: March 13, 2009   History of Changes
Sponsors and Collaborators: University of California, Irvine
Beckman Laser Institute University of California Irvine
Ophthalmology department, University of California,Irvine
Information provided by: University of California, Irvine
ClinicalTrials.gov Identifier: NCT00556114
  Purpose

At Beckman Laser Institute, University of California, Irvine, the investigators have developed diagnostic device call 'optical coherence tomography (OCT).' The imaging technique used in clinical ophthalmology during eye examination, which is imaging the eye (retina), and to diagnose and manages many eye diseases.

The study is used to diagnose and manage retinal diseases, including choroidal, optic nerve head vessels in macular degeneration, vitreomacular traction syndrome, diabetic retinopathy, retinoschisis, macular edema, central serous chorioretinopathy, optic nerve disorders, and nerve fiber layer evaluation in glaucoma, and to compare these to normal controls.

Growing evidence shows that altered blood flow plays a major role in many vision-threatening diseases, although they account for the majority of cases of severe vision loss and blindness in the United States and worldwide.


Condition Intervention
Glaucoma
Diabetic Retinopathy
Age-Related Macular Degeneration
Device: OCT

Genetics Home Reference related topics: early-onset glaucoma X-linked juvenile retinoschisis
MedlinePlus related topics: Diabetic Eye Problems Glaucoma Macular Degeneration Retinal Disorders
U.S. FDA Resources
Study Type: Observational
Study Design: Case Control, Prospective
Official Title: A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging

Further study details as provided by University of California, Irvine:

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 60
Study Start Date: January 2007
Estimated Study Completion Date: July 2012
Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1 Device: OCT
OCT eye exam imaging

Detailed Description:

OCT is a non-invasive technique that provides high-resolution cross-sectional images of the retina at unprecedented resolutions as small as a few microns. OCT uses a broadband light source to illuminate the area of study with light in the near infrared spectrum, then obtains static images of tissue structure from interference signals of the back-reflected light.

The subject is required to look into an eyepiece on the exam device at a green blinking fixation light illuminated on a dimly lighted background. OCT non-invasive technique takes from 0.32 seconds to 1.92 seconds for the image to be acquired, then 5-10 seconds to be displayed and to determine if the image quality is sufficient. Approximated 4-5 images are taken.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Primary care clinic and community sample.

Criteria

Inclusion Criteria:

  • Adult 18 years and older with normal eye, or has been diagnosed with eye disease.

Exclusion Criteria:

  • Less than 18 years of age.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00556114

Locations
United States, California
Beckman Laser Institute, University of California,Irvine
Irvine, California, United States, 02612
Sponsors and Collaborators
University of California, Irvine
Beckman Laser Institute University of California Irvine
Ophthalmology department, University of California,Irvine
Investigators
Principal Investigator: Baruch D Kuppermann,, M.D., Ph.D. Ophthamology, University of California,Irvine
Principal Investigator: Zhongping Chen, Ph,D Beckman Laser Institute University of California Irvine
  More Information

No publications provided

Responsible Party: Beckman Laser Institute ( Baruch D. Kuppermann,, M.D., Ph.D. )
Study ID Numbers: NIH OCT EB-093-07, LAMMP NIH
Study First Received: November 7, 2007
Last Updated: March 13, 2009
ClinicalTrials.gov Identifier: NCT00556114     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, Irvine:
eye exam
Retina

Study placed in the following topic categories:
Eye Diseases
Vascular Diseases
Diabetes Mellitus
Macular Degeneration
Endocrine System Diseases
Retinal Degeneration
Diabetic Angiopathies
Diabetic Retinopathy
Glaucoma
Endocrinopathy
Retinal Diseases
Diabetes Complications
Ocular Hypertension
Hypertension

Additional relevant MeSH terms:
Eye Diseases
Vascular Diseases
Diabetes Mellitus
Macular Degeneration
Endocrine System Diseases
Retinal Degeneration
Diabetic Angiopathies
Diabetic Retinopathy
Glaucoma
Cardiovascular Diseases
Retinal Diseases
Diabetes Complications
Ocular Hypertension

ClinicalTrials.gov processed this record on May 07, 2009